Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medik8
United Kingdomus.medik8.com ↗
- Ownership
- Private
- Employees
- ~300
- Development stage
- Other
01
Overview
Medik8 has achieved robust commercial and clinical (cosmeceutical) performance, especially with its proprietary retinal (retinaldehyde)-based Crystal Retinal line, shown in independent studies to provide significant visible skin improvement and minimal irritation. Their range includes patented, peer-reviewed formulas for vitamin A, C, peptides, and sunscreen with strong user and dermatologist recommendations[1][2][3][4].
- Therapeutic areas
- Dermatology
- Modalities
- Small moleculePeptidesRetinoid (Vitamin A derivatives)Antioxidant
- Industry
- Non-Drug Biotech
02
Partnerships
L'Oréal (majority owner, 2024)[2][4]Inflexion (minority stakeholder)[2][4]
Beyond the preview
Go deeper on Medik8.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Medik8.